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1. Introduction 
Fournier’s gangrene (FG) is a fulminant and life-threatening disease characterized by 
necrotizing fascitis of the perineal and genitourinary area resulting from polymicrobial 
infection. The polymicrobial organisms cause ascending reactions, activating various 
proteins and enzymes, leading to platelet aggregation, intravascular coagulation, tissue 
ischemic tissue change. This disease rapidly progresses, causing thrombosis and irreversible 
necrosis. 
Most of patients had predisposed or concomitant diseases such as diabetes mellitus, 
alcoholism, hepatic diseases, renal diseases, and cardiac diseases.  
It is a surgical emergency and requires prompt surgical debridement in most cases. For the 
treatment of Fournier’s gangrene, aggressive wide necrotic tissue debridement for survival 
and the proper use of antibiotics, post-operative wound management, and proper 
reconstruction are required.  
High mortality rates in Fournier’s gangrene range from 6.3 to 50%, which indicates that the 
variable outcome of patients with the disease is multifactorial. In general, disease related 
factors and host-related factors are important prognostic factors.  
To investigate clinical features and prognostic factors in patients who underwent the 
treatments of Fournier’s gangrene, Acute Physiology and Chronic Health Evaluation 
(APACHE) II, and the Fournier’s Gangrene Severity Index (FGSI) score which was first 
reported by Laor et al in 1995 were used and other scoring system. Among them, the FGSI 
is very useful and it can predict mortality and survival with a high probability for patients 
with Fournier’s gangrene according to many authors. The quantification of the extent of 
the disease may help determine the outcome more precisely predictions for patients with 
Fournier’s gangrene. 
We analyzed 27 patients who underwent treatments due to Fournier’s gangrene in our 
institution and evaluated predictive factors for mortality and survival based on 
pathogenesis, causative factors, and the subjects of progression. The result of this study 
showed that sepsis and FGSI of nine points or over at the time of hospitalization were 
significant risk factors for mortality. 
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2. History and pathophysiology of Fournier gangrene  
2.1 History   
Fournier’s gangrene was first described by Jean Alfred Fournier (1832-1914) in 1883, a 
French dermatology/venereologist, a series in which previously healthy young men. He 
used the term-’fulminant gangrene-sudden onset necrotizing disease, rapid progression to 
gangrene and absence of a definite cause’ of the penis and scrotum and his description was 
based on five young men with scrotal gangrene. Although this disease has been still called 
Fournier’s gangrene to date, its concept has been changed and its causes have been 
identified in most cases. This condition is described as infective necrotizing fascitis which 
occurs in perineal, perianal, and genitourinary areas due to polymicrobial organisms 
regardless of gender and age.  
Since Fournier’s gangrene was first described, various changes have been made in the 
definition of the disease and its treatment methods. 
2.2 Pathophysiology 
Localized infection adjacent to a portal of entry is the inciting event in the development of 
Fournier gangrene. The polymicrobial organisms cause ascending reactions, activating 
various proteins and enzymes, leading to platelet aggregation, intravascular coagulation, 
tissue ischemic change. This disease rapidly progresses, causing thrombosis and irreversible 
necrosis in perineal and genitourinary areas. 
It has been revealed that Fournier gangrene is a polymicrobial infection with an average of 2~4 
isolates per case at wound cultures from patients. The bacteria involved act synergistically, via 
collagenases, hyaluronidases, and other enzymes to invade and destroy fascial planes 
Ultimately, an obliterative endarteritis develops, and the ensuing cutaneous and 
subcutaneous vascular necrosis leads to localized ischemia and further bacterial 
proliferation. Rates of fascial destruction as high as 2-3 cm/h have been described in some 
reports. Infection of superficial perineal fascia (Colles fascia) may spread to the penis and 
scrotum via Buck and Dartos fascia, or to the anterior abdominal wall via Scarpa fascia, or 
vice versa. Perineal fascia is attached to the perineal body and urogenital diaphragm 
posteriorly and to the pubic rami laterally, thus limiting progression in these directions. 
Testicular involvement is rare, as the testicular arteries originate directly from the aorta and 
thus have a blood supply separate from the affected region.  
2.3 Outcome/prognosis 
Despite the development of modern intensive care and medical therapy, mortality rate from 
Fournier gangrene remains still high. The mortality rate for Fournier gangrene widely varies 
from 30 to 50%. 
Prognosis may be affected by various factos, that include disease-related and host-related 
ones. The outcome of patients with the disease is indicated multifactorial. 
Factors associated with high mortality include an anorectal source, advanced age, extensive 
disease (involving abdominal wall or thighs), shock or sepsis at presentation, renal failure, 
and hepatic dysfunction. Death usually results from systemic illness, such as sepsis, 
coagulopathy, acute renal failure, diabetic ketoacidosis, or multiple organ failure.  
Most studies were conducted to investigate clinical features and prognostic factors in 
patients who underwent the treatments of Fournier’s gangrene at a single institution. 
Progression to single-organ or multiorgan failure (MOF, MODF) may occur, usually as a 
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result of gram-negative sepsis and is typically the cause of death. (Include acute renal failure 
and adult respiratory distress syndrome). 
After recovering from a threatening condition, large scrotal, perineal, penile, and abdominal 
wall skin defects may require reconstructive procedures. Fatal tetanus associated with 
Fournier gangrene has been reported in the literature. 
3. Clinical feature  
3.1 Frequency 
Fournier gangrene is relatively uncommon. The true incidence of the disease is unknown. A 
retrospective case review revealed 1726 cases documented in the literature from 1950 to 
1999. An average of 97 cases per year was reported from 1989 to 1998. Poor socioeconomic 
conditions contribute to development of Fournier’s Gangrene. However, regional 
prevalence and Ethnicity were not identified as relevant factors. 
3.2 Age and sex 
Mostly male-to-female ratio is mostly approximately 10:1 in large series. Rare reports 
including women, especially with postpartum perineal necrotizing fasciitis, but, the lower 
incidence in females may be caused by better drainage of the perineal region through 
vaginal secretions. Homosexual men may be at a higher risk of contracting Fournier 
gangrene; especially for infections caused by community-associated methicillin-resistant 
Staphylococcus aureus (MRSA).  
Most cases occur in patients aged 30-60 years. When Fournier’s gangrene was first described 
by Alfred Fournier, ‘young age and male gender’were identified. The reported age of 
patients with the disease has progressively increased in the published data. In 1945, It was 
reported an average age of 40.9 years was reporeted; in 1979, Jones reported 51.3 years; Laor 
and colleagues reported an average age of 61 years old. In our analysis, we found an almost 
identical average of 57.3 years. 
In our study, the male subjects composed 25 cases (92.6%) and the mean age of the subjects 
was 52.8 years. The age bracket of patients with Fournier’s gangrene has commonly been 
found to be between 30 and 60 years. In this study, the mean age was 52.8 years and the 
patients with an age of less than 65 years accounted for 70.4 % of all subjects.  
Regarding determinants of survival in older FG patients, it is now known that older patients 
have a lower survival rate. Clayton et al. statistically found that patients who survived were 
younger statistically than those who died of Fournier’s gangrene (52 and 69 years old, 
respectively). Yilmazlar et al calculated a threshold age of 60 years in the ROC analysis (area 
under ROC curve: 0.709, 95%CI: 38.5–81.8). Logistic regression analysis identified age as an 
independent risk factor for mortality in large patients with Fournier’s gangrene.  
3.3 Predisposition to disease 
Many predisposing factors have been reported, including systemic disease such as diabetes 
mellitus, alcoholism, chronic renal failure, chronic steroid use, malnutrition, HIV infection, 
and malignancy in FG. Any condition with decreased cellular immunity may predispose to 
the development of Fournier gangrene theoretically.  
In our series, the concomitant diseases included diabetes mellitus in 29.6%; liver cirrhosis 
and alcoholic liver disease in 14.8% in our study. Diabetes mellitus was the most common 
comorbidity associated with FG and was present in 50% (24-72) of patients at the time of 
admission. Table 1 
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*Fournier’s gangrene severity index 
Table 1. Clinical feature and Outcome in patients with Fournier’s gangrene  
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Diabetes has always been associated with an increased incidence of FG. Many authors 
reported the prevalence of diabetes as 50~73 percent, respectively. The high incidence of 
diabetics in FG was explained by the increased propensity to tissue ischemia caused by 
small-vessel disease. On the other hand, diabetes is associated with worse outcome and 
increased mortality, which could be explained by mutifactorial immunological system 
dysfunction, that included decreased phagocytosis ability, neutrophil dysfunction.  
Although this association of unfavorable outcome and underlying diabetes has previously 
been mentioned, numerous review articles have failed to demonstrate a statistically 
significant difference.  
One of the 15 nondiabetic patients died; however, the mortality rate among diabetics was 
higher (3 of 12 patients, 25 percent).  
For pathogenesis, anorectal diseases were the most frequent causes of the infection. 
In our retrospective review of 27 consecutive patients treated for FG at a single institution, 
factors such as the presence of sepsis, high FGSI and the initial surgical intervention affected 
outcome in univariate analyses.  
The concomitant diseases of Fournier’s gangrene have been known to include diabetes 
mellitus, alcoholism, chronic liver disease, various cancers, and immune suppression.  
In this study, diabetes mellitus was found in eight patients; liver cirrhosis and alcoholic liver 
disease in four patients; and hypertension in nine patients. Bed ridden status due to 
paraplegia was also found in some patients. 
3.4 Causative factors  
Anorectal, genitourinary, and dermatologic sources are implicated in the pathogenesis of 
the disease. Localized infection adjacent to a portal of entry is often the inciting event in the 
development of Fournier gangrene. Table 2.  
In men, anal intercourse may increase risk of perineal infection, either from blunt trauma to 
the area or by spread of anorectal microbes.  
In women, septic abortions, hysterectomy, and episiotomy, vulvar or Bartholin gland 
abscesses are also documented sources. 
Poor perineal hygiene or the presence of chronically indwelling catheters, such as in 
paraplegic patients, poses an increased risk in box sex.  
 
 
Anorectal  
Trauma 
Ischiorectal, perirectal, or perianal abscesses 
Perianal fistulotomy 
Anal fissures; colonic perforations 
steroid enemas for radiation proctitis 
Rectal cancer 
Genito urinary  
Trauma 
Urethral strictures with urinary extravasation  
Urethral catheterization or instrumentation, penile implants 
Periurethral infection ; chronic urinary tract infections;  
Epididymitis or orchitis 
Penile artificial implant, Foreign body   
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Hemipelvectomy  
Cancer invasion to external genitalia 
Septic abortion 
Bartholin’s duct abscess  
Episiotomy  
Dermatologic sources  
Scrotal furuncle  
Genital toilet (scrotum)  
Blunt perineal trauma ; intramuscular injections, genital piercings 
Perineal or pelvic surgery /Inguinal herniography  
Idiopathic;  more than 75% 
Table 2. Causative Factors in Patients With Fournier’s Gangrene 
3.5 Clinical presentation 
In general, most patients were reported to visit hospitals due to itching or discomfort of the 
external genitals. It was reported to take approximately 5 days from symptom expression to 
visiting the hospital. In this study, most patients suffered from perianal/scrotal swelling 
and pain as a main symptom. In addition, fever and chill, perianal/scrotal necrosis, 
purulent discharge, and voiding difficulty were also accompanied. The mean duration from 
the initiation of symptom expression to visiting the hospital was 99.8 hours, i.e. 4-5 days. 
When the patients were divided into anorectal and genitourinary groups and the 
characteristics of the subject groups were compared, no significant difference except for 
fecal diversion was found between the two groups. For anorectal diseases, fecal diversion is 
thought to be frequently conducted as wound management was difficult due to fecal 
contamination and the surgery site was perianal area.    
All patients had at least one of the following early symptoms or signs: perianal or perineal 
pain, hyperemia, and fever. 
The clinical presentation of the disease starts with a prodromal period of genital discomfort 
or pruritus, followed by genital erythema, swelling, crepitation and revealing subcutaneous 
gas formation.  
Skin overlying the affected region may be normal, erythematous, edematous, cyanotic, 
bronzed, indurated, blistered, and/or frankly gangrenous in progression.  
However, skin appearance often underestimates the degree of underlying disease. A 
feculent odor may be present secondary to infection with anaerobic bacteria. The 
gangrenous process will lead to drainage of the affected areas and demarcation between 
viable and dead tissue. The extent of the involved area may reach the abdominal wall, axilla, 
and thighs. 
Crepitus may be present, but its absence does not exclude the presence of Clostridium species 
or other gas-producing organisms. Systemic symptoms (eg, fever, tachycardia, and 
hypotension) may be present.  
In Fournier gangrene, obtain a thorough review of systems, including history of diabetes, 
alcohol abuse, cancer, colorectal or urogenital disease or surgery, steroid use, sexual history, 
and HIV status.  
Sepsis at presentation was found in seven cases (25.9%). The mean duration from the 
expression of the symptoms to visiting the hospital was 99 hours. 
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3.6 Bacteriology 
Both anaerobic and aerobic organisms isolated from wound cultures have been cited as an 
important bacteriologic principle in Fournier’s gangrene. Paty and Smith found E. coli, 
Bacteroides, and streptococci to be the most common organisms. 
Laor et al. determined the most common organisms were E. coli and Streptococcus species, 
with Staphylococcus and Enterococcus more commonly isolated than Bacteroides. 
The mean microbial number of two was identified in microbial culture tests. Streptococcus. 
species was the most common microbial organism, accounting for 48.1%. Enterococcus and 
Escherichia Coli were found in 29.6% and 25.9%, respectively in our study. Table 3. 
 
 
Bacterial organism % 
Streptococcus. Species 48.1 
Enterococcus 29.6 
Escherichia Coli 25.9 
Unspecified G(+) rods 25.9 
Klebsiela pneumoniae 18.5 
Unspecified G(-) rods 14.8 
Bacteroides species 1.1 
Unspecified G(+) cocci 11.1 
Coagulase-negative staphylococcus 7.4 
Enterobacter species 7.4 
Acinetobacter 3.7 
Candida albicans 3.7 
 
 
Table 3. Causative Bacterial organism of FG 
The mean numbers of isolated microorganism per patient was reported to be four, and 
Escherichia Coli and Bacteroides were reported to be the most common microbes. In addition, 
Proteus, Staphylococcus, Pseudomonas, and Klabsiella were also reported. According to the 
results of this study, one to three microbes were identified. Streptococcus species and 
Enterococcus were common microbes, and Klebsilla and Bacteroides were also commonly 
identified as shown in previous study results.  
Wound culture results from our series were similar to prior reported results with 
predominantly polymicrobial infections. It reveals a polymicrobial infection with an average 
of 4 isolates per case. Streptococcus species is the predominant aerobe, and Bacteroides is the 
predominant anaerobe. 
Other microflora includes Proteus, Staphylococcus, Enterococcus, aerobic and anaerobic 
Streptococcus, Pseudomonas, Klebsiella, and Clostridium. Incidence of methicillin-resistant 
Staphylococcus aureus (MRSA) may be increase in being mentioned in literature 
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FG has always been considered a surgical emergency. Some articles have so far highlighted 
the poor prognosis of FG in patients with a delay in presentation and treatment.  
In most studies the course of these patients was characterized by a more advanced disease 
necessitating more aggressive debridement with fecal diversion.  
There are limitations in the design and interpretation of this study. First, we still have 
relatively few cases that were treated during a long period. Second, the retrospective 
study, the extent of the disease in terms of surface area and other prognostic variables 
were not included. 
4. Differential diagnoses 
- Balanitis, Epididymitis, Orchitis  
- Testicular Torsion 
- Hernias, Hydrocele  
- Cellulitis, Gas Gangrene and 
- Necrotizing Fasciitis  
Cellulitis is used to indicate a nonnecrotizing inflammation of the skin and subcutaneous 
tissues, a process related to acute infection that does not involve the fascia or muscles. 
Cellulitis was classically considered to be an infection without formation of abscess and 
without purulent drainage or ulceration.  
Gas gangrene, a subset of necrotizing myositis, is an emergent infectious disease. Organisms 
in the spore-forming clostridial species, including Clostridium perfringens, Clostridium 
septicum, and Clostridium novyi, cause most of the cases. A nonclostridial form is caused by a 
mixed infection of aerobic and anaerobic organisms. Disease has rapid onset of myonecrosis 
with muscle swelling, severe pain, gas production, and sepsis. 
For more than a century, many authors have described soft tissue infections. Their 
occurrence has been on the rise because of an increase in immunocompromised patients 
with diabetes mellitus, cancer, alcoholism, vascular insufficiencies, organ transplants, HIV, 
or neutropenia.  
Necrotizing fasciitis can occur after trauma or around foreign bodies in surgical wounds, or 
it can be idiopathic, as in scrotal or penile necrotizing fasciitis.  
Necrotizing fasciitis has also been referred to as hemolytic streptococcal gangrene, Meleney 
ulcer, acute dermal gangrene, hospital gangrene, suppurative fascitis, and synergistic 
necrotizing cellulitis. Fournier gangrene is a form of necrotizing fasciitis that is localized to 
the scrotum and perineal area.  
Necrotizing fasciitis is a progressive, rapidly spreading, inflammatory infection located in 
the deep fascia, with secondary necrosis of the subcutaneous tissues. Because of the 
presence of gas-forming organisms, subcutaneous air is classically described in necrotizing 
fasciitis. The speed of spread is directly proportional to the thickness of the subcutaneous 
layer. Necrotizing fasciitis moves along the deep fascial plane, rapidly progress. They 
require aggressive treatment to combat the associated high morbidity and mortality.  
5. Diagnostic methods 
5.1 Laboratory studies 
The following studies are indicated in patients Fournier gangrene: 
• CBC with differential count 
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• Electrolytes, BUN, creatinine, blood glucose levels: Acidosis with hyperglycemia or 
hypoglycemia may be present. Dehydration occurs as the disease progresses.  
• ABG sampling to provide a more accurate assessment of acid/base disturbance 
• Blood and urine cultures 
• Disseminated intravascular coagulation (DIC) panel (coagulation studies, 
fibrinogen/fibrin degradation product levels) to find evidence of severe sepsis  
• Cultures of any open wound or abscess 
5.2 Imaging studies Fournier gangrene 
Diagnosis of Fournier gangrene is primarily is based on clinical findings. Sensitivities and 
specificities of different radiologic modalities are not established.  
Conventional radiography 
Conventional radiography may demonstrate soft-tissue gas collections (manifest as areas of 
hyperlucency), even4 before they are clinically apparent. Scrotal tissue edema may be 
observed on radiographs. Absence of air on plain films does not exclude the diagnosis. 
Ultrasonography 
Ultrasonography may reveal other causes of acute scrotal pain, including intratesticular 
injury, scrotal cellulitis, epididymoorchitis, testicular torsion, and inguinal hernia. 
Gas in the scrotal wall is the "sonographic hallmark" of Fournier gangrene. Air may be 
appreciated in perineal and/or perirectal areas. Scrotal wall edema may be seen. Testes and 
epididymides are usually normal. 
Computerized tomography 
Findings include soft-tissue and fascial thickening, fat stranding, and soft-tissue gas 
collections. CT scans defines the extent of the disease more specifically. CT scan often 
identifies the underlying cause of the infection (eg, perirectal abscess). This modality may 
assist in surgical planning. 
MRI 
MRI use is not well described in the literature. MRI may define soft-tissue pathology more 
distinctly than CT scan but should not delay operative intervention if the diagnosis is highly 
suspected.  
6. Treatment & management 
6.1 Resuscitation & early care 
The following treatment is indicated in patients with Fournier gangrene: 
• Initially, aggressive resuscitation in anticipation of surgery - Airway management if 
indicated, crystalloid replacement if dehydrated or displaying signs of shock  
• Supplemental oxygen, intravenous (IV) access, and continuous cardiac monitoring 
Early, broad-spectrum antibiotics are indicated, including the following: 
• Ampicillin/sulbactam 
• Ticarcillin/clavulanate 
• Piperacillin/tazobactam 
• Penicillinase-resistant penicillin, aminoglycoside, and metronidazole or clindamycin 
• Coverage for methicillin-resistant Staphylococcus aureus (MRSA), such as vancomycin 
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Tetanus prophylaxis is indicated if soft-tissue injury is present. 
Irrigation with superoxidized water and packing with gauze soaked with zinc peroxide and 
hydrogen peroxide may be helpful. 
Surgical consultation is imperative. Immediate urologic, colorectal consultation is 
mandatory. 
6.2 Medication summary 
The goals of pharmacotherapy in Fournier gangrene are to reduce morbidity and to control 
the infection. 
Antibiotics 
Initiate early broad-spectrum antibiotics as soon as possible. Providing coverage for gram-
positive, gram-negative, aerobic, and anaerobic bacteria is essential. Penicillins and beta-
lactamase inhibitors or triple antibiotics are potential choices.  
Vancomycin  
Ampicillin-sulbactam sodium  
Ticarcillin and clavulanate potassium 
Piperacillin/tazobactam  
Gentamicin  
Metronidazole  
Clindamycin  
6.3 Immunizations 
Patients with fatal tetanus associated with Fournier gangrene have been documented in 
literatures. Patients with noncurrent tetanus status require immunization in the emergency 
department.  
Diphtheria and tetanus toxoid (Decavac) 
Tetanus toxoid is manufactured by first culturing Clostridium tetani and then detoxifying the 
toxin with formaldehyde. This toxoid is commonly combined with diphtheria toxoid, and 
both serve to induce production of serum antibodies to toxins produced by the bacteria.  
6.4 Surgical management 
Aggressive surgical debridement may have a positive effect on survival. Although Clayton 
et al. and Laor et al. suggested that the extent of disease was not predictive of outcome, 
Spirnak et al. associated the greater mortality rate for patients who underwent more 
frequent operations to the presence of a greater extent of the disease. Others found that the 
extent of body surface area involved in the necrotizing process was directly related to 
mortality. 
Surgeon or urologist may order further diagnostic tests in patients with Fournier gangrene, 
including cystourethroscopy, retrograde urethrography, sigmoidoscopy, barium enema, 
tissue biopsy, and examination under anesthesia.  
Urinary and/or fecal diversion (eg, suprapubic catheterization, ileostomy or colostomy) 
may be required depending on the source of infection.[5]  
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If the initial facility does not have the capability to provide operative therapy in a timely 
fashion, arrange for transfer once the patient has been stabilized and resuscitative efforts 
have begun. Patients often require a multidisciplinary team, including urologist, general 
surgeon, and team for intensive care. Transfer to a tertiary facility may be required if these 
resources are not available at the initial facility. 
Multiple surgical debridements in the operating room may be required to effectively remove 
all necrotic tissue. Patients with Fournier gangrene undergo an average of 2-4 operative 
procedures during their initial hospitalization. In our study, 17 cases (63%), required 
surgical treatments of fecal or urinary diversion. Orchiectomy and/or penectomy are rarely 
required.  
Reconstructive surgery due to wide wound defects was required in 11 cases (40.7%). The 
mean length of stay in hospital was 70.8 days. 
Hyperbaric oxygen therapy (HBO) has been used as an adjuvant to surgical and 
antimicrobial therapy, especially in patients for whom conventional treatment failed, in 
those with documented clostridial involvement, or in those with myonecrosis or deep tissue 
involvement. HBO is postulated to reduce systemic toxicity, prevent extension of 
necrotizing infection, and inhibit growth of anaerobic bacteria. However, in one series, there 
was actually a trend toward increased mortality in patients undergoing HBO therapy.  
Decisions regarding hyperbaric therapy must be made on an individual basis and should be 
an adjuvant to debridement and antimicrobial therapy.  
7. Outcome and prognosis  
There is no consensus on which clinical variables predict a poor outcome in FG. 
Retrospective studies have implicated increasing age, diabetes mellitus, delay in 
presentation / treatment and extent of involvement (BSA, Body Surface area). While BSA 
was suggestive of a poor prognosis of all the operative characteristics examined, only lower 
extremity or abdominal wall involvement was associated with inpatient mortality.  
Previous reports suggest that older, debilitated or bedridden patients with multiple 
comorbidities presenting with advanced FG are more likely to have poor outcomes. Factors 
associated with an improved prognosis include age younger than 60 years, localized clinical 
disease, absence of systemic toxicity, and sterile blood cultures.  
Four patients (14.8%) died during the treatment; three patients due to sepsis and one patient 
who had scrotal abscess accompanied with incarcerated inguinal hernia died due to renal 
failure. However, our results indicate that with, age, comorbidity, use of early aggressive 
therapy and time to presentation do not affect prognosis.  
For host related factors, the novel scoring system should be validated through other 
prospective studies and independent observations and can be applied in clinical practice 
The number of patients with FG is significant and the mortality ranges between 15 to 50%, 
showing various prognoses. Higher mortality was reported to be seen in the cases of anal 
diseases, the elderly, diabetes mellitus, invasion to the abdominal wall and the thigh, higher 
FGSI, shock and sepsis at the time of hospitalization, and accompanying hepatic failure and 
renal failure.  
The FGSI was developed to help clinicians predict outcome in patients with FG. Table 4. A 
score of 0-4 is assigned to each of the following parameters: temperature; heart rate; 
respiratory rate; serum sodium, potassium, bicarbonate, and creatinine levels; hematocrit; 
and WBC count. Its modified scoring system also has been developed, which has been 
shown to aid in prognosis. Table 5.  
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High Abnormal Values Normal Low Abnormal Values 
Physiologic Variables 
/ Point assignment  
+4 +3 +2 +1 0 +1 +2 +3 +4 
Temperature (C) [ >41 39–40.9 ─ 38.5–
38.9 
36–38.4 
34–
35.9 
32–33.9 30–31.9 <29.9 
Heart rate (bpm) >180 140–179 110–139 ─ 70–109 ─ 55–69 40–54 <39 
Respiratory rate  >50 35–49 ─ 25–34 12–24 10–11 6–9 ─ <5 
Serum potassium 
(mmol/L)  
>7 6–6.9 ─ 5.5–5.9 3.5–5.4 3–3.4 2.5–2.9 ─ <2.5 
Serum sodium 
(mmol/L) 
>180 160–179 155–159 150–154 130–149 ─ 120–129 110–119 <110 
Serum creatinine 
(mg/100 ml) 
(x2 for acute renal 
failure) 
>3.5 2-3.4 1.5-1.9 ─ 0.6-1.4 ─ <0.6 ─ ─ 
Hematocrit (%)  >60 ─ 50–59 46–49 30–45 ─ 20–29 ─ <20 
White blood count 
(91000/mm3)  
>40 ─ 20–39.9 15–19.9 3–14.9 ─ 1–2.9 ─ <1 
Serum bicarbonate, 
(venous) (mmol/L)  
>52 41–51 ─ 32–40 22–31 ─ 18–21 15–17 <15 
 
 
Table 4. Fournier’s gangrene severity index 
Laor et al reported that a FGSI score greater than 9 indicated a 75% probability of mortality 
while a score of 9 or less was associated with a 78% probability of survival. This cutoff point 
has subsequently been validated in other small retrospective series. However, Tuncel et al of 
20 men with FG demonstrated no association between FGSI and mortality, and stated that 
specific metabolic parameters (serum albumin and alkaline phosphatase), predisposing 
factors and disease extent should be assessed together to predict treatment outcome and 
survival. 
In our study, the mean FGSI was 9.25 in patients who had died and 4.69 in patients who 
survived. Of the factors affecting the mortality, sepsis and FGSI of 9 points or over at the 
time of hospitalization were statistically significant. Table 6. 
The morbidity of FG has been gradually increasing and its causal diseases and causal 
microbes have also varied. For the treatment of Fournier’s gangrene, active wound 
managements such as early diagnosis, wide excision for necrotic tissue, the proper use of 
antimicrobials, and continuous postoperative aseptic dressing are required.  
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Variables +4 +3 +2 +1 0 +1 +2 +3 +4 
a. Physiological parameters         
Temperature (C) [ >41 39–40.9 ─ 38.5–
38.9 
36–38.4 34–35.9
32–
33.9 
30–31.9 <29.9 
Heart rate  >180 140–179 110–139 ─ 70–109 ─ 55–69 40–54 <39 
Respiratory rate  >50 35–49 ─ 25–34 12–24 10–11 6–9 ─ <5 
Serum potassium 
(mmol/L)  
>7 6–6.9 ─ 5.5–5.9 3.5–5.4 3–3.4 2.5–2.9 ─ <2.5 
Serum sodium 
(mmol/L) 
>180 160–179 155–159 150–154 130–149 ─ 120–
129 
110–
119 
<110 
Serum creatinine 
(mg/100 ml) 
(x2 for acute renal 
failure) 
>3.5 2-3.4 1.5-1.9 ─ .6-1.4 ─ <0.6 ─ ─ 
Hematocrit (%)  >60 ─ 50–59 46–49 30–45 ─ 20–29 ─ <20 
White blood count 
(91000/mm3)  
>40 ─ 20–39.9 15–19.9 3–14.9 ─ 1–2.9 ─ <1 
Serum bicarbonate, 
(venous) (mmol/L)  
>52 41–51 ─ 32–40 22–31 ─ 18–21 15–17 <15 
b. Dissemination score 
  
Fournier’s gangrene confined to the urogenital and/or anorectal region, add ‘‘1’’ 
Fournier’s gangrene confined to the pelvic region, add ‘‘2’’ 
Fournier’s gangrene extending beyond the pelvic region, add ‘‘6’’ 
c. Age score  
Age ≥60 years, add ‘‘1’’  
Age <60 years, add ‘‘1’’  
 
 
 
UFGSI = A+B+C 
Table 5. The Uludag Fournier’s gangrene severity index  Yilmazlar T et al (2007) 
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  Total 
N=27 
Mortality 
N=4(%), 
Odds ratio(95%, CI) p 
 
Age (years) <65  
≥65  
19  
8  
3 (15.8) 
1 (12.5)  
0.762 (0.067-8.665)  1.000  
Duration  
of symptoms 
<48 hours 
>48 hours  
9  
18  
1 (11.1) 
3(16.7)  
1.600(0.142-18.000)  1.000  
Infection source Anorectal  
Genitourinary  
16  
11  
2 (12.5) 
2 (18.2)  
1.556 (0.185-13.108)  1.000  
Sepsis Present 
Absent  
7  
20  
3 (42.9) 
1 (5.0)  
14.250 (1.162-174.801)  0.042  
FGSI* ≤9 
>9  
24 
3  
2 (8.3) 
2 (66.7)  
22.000(1.334-362.916)  0.049  
DM or Liver  
disease  
Present 
Absent  
12  
15  
3 (25.0) 
1 (6.7)  
4.667 (0.418-52.121)  0.294  
No of 
Debridement  
<2 
≥2  
9  
18  
3 (33.3) 
1 (5.6)  
0.118 (0.010-1.359)  0.093  
Diversion Performed 
Not performed  
17  
10   
2 (11.8) 
2 (20.0)  
0.533 (0.063-4.531)  0.613  
 
*FGSI, Fourier’s gangrene severity index 
Table 6. Prognostic factors for mortality of Fournier’s gangrene   Kim KM et al 2010 
 
 Survival vs. 
Nonsurvival  (N) 
p References 
Age (years) 
FGSI(median) 
Extent of the disease (Grade I,II, III) 
Need for ICU 
Need for Ventilator 
Length of Hospital stay 
 (days, median) 
63 vs. 17 0.002  
<0.001 
<0.001 
<0.001 
<0.001 
 
0.002 
Yilmazlar et al 2010 
 
RR  
Tempaerature 
Median BSA* 
Charlson  Comorbidity Index 
Life expectancy for 10 y (%) 
14 vs. 4 0.003 
0.046 
0.018 
0.008 
0.008 
Erol et al 2009 
RR  
Serum bicarbonate 
FGSI 
Serum lactate 
Serum calcium 
61 vs. 7 0.021 
0.001 
0.006 
0.001 
0.032 
Corcoran et al 2008 
Time to consult 
BSA 
FGSI 
19 vs. 6 0.002 
0.0001 
0.0001 
Yeniyol et al 2004 
Sepsis 
FGSI*  ≤9 vs. >9 
23 vs. 4  0.042  
0.049  
Kim et al 2010 
 
 
BSA _ body surface area. 
Table 7. Prognostic factors for mortality of Fournier’s gangrene  
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Aggressive and early surgical débridement continues to be the mainstay of treatment of FG 
in most series. It was reported that the number of operative débridements negatively affects 
survival, speculating that patients requiring multiple débridements had greater extent of 
disease, were less healthy at baseline and had progressed to systemic sepsis despite 
aggressive surgical therapy. Factors confounding the significance of the number of 
débridement necessary for disease control among survivors include total surface area 
involved, variation in the extent of the initial resection and whether the patient is healthy 
enough to survive multiple procedures 
The result of our study showed that sepsis and FGSI of nine points or over at the time of 
hospitalization were statistically significant as factors affecting mortality. The patients 
included in the aforementioned criteria could show poor prognoses such as DIC, acute renal 
failure, acute renal failure, and multiorgan failure.  
If necessary, hyperbaric oxygen therapy can be helpful, and furthermore, reconstruction 
surgery may be necessary later.   
In this study, FG was investigated in relatively many cases at a single institution compared 
to other studies conducted in Korea. Further studies with a larger subject population will be 
required.   
8. Conclusion  
Despite the development of modern intensive care and medical therapy, Fournier’s 
gangrene remains a fulminant and life-threatening disease, mortality rates have improved 
as a result of advances in surgical and critical care. Early diagnosis and surgical treatment of 
Fournier’s gangrene are required. 
Comprehensive evaluation of metabolic and physiological parameters, predisposing factors, 
and the extent of disease are also essential for early diagnosis and treatment. 
There is no current consensus regarding the use of individual patient admission 
characteristics or laboratory values as prognostic indicator, sepsis at presentation and lower 
extremity/abdominal wall involvement were associated with disease severity and inpatient 
mortality in large series.  
The FGSI remains a simple method of assessing severity of presentation and predicting 
outcome in this complex patient population.  
Poor prognoses were seen in the cases of sepsis and FGSI of nine points or over at the time 
of hospitalization. Our results support previous findings that a FGSI threshold of 9 is a 
sensitive and specific predictor of mortality during initial assessment. Therefore, the careful 
observation of vital signs and active treatments are required to treat Fournier’s gangrene.  
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